🇺🇸 FDA
Patent

US 10130676

Therapeutic peptides for cerebrovascular diseases

granted A61KA61K38/00A61K38/08

Quick answer

US patent 10130676 (Therapeutic peptides for cerebrovascular diseases) held by Prime Bio-Drug Development Limited expires Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Prime Bio-Drug Development Limited
Grant date
Tue Nov 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61P